Suppr超能文献

颅内狭窄支架置入强化药物治疗预防复发性卒中试验中危险因素控制与生活方式改变计划依从性之间的关系

Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.

作者信息

Turan Tanya N, Al Kasab Sami, Nizam Azhar, Lynn Michael J, Harrell Jamie, Derdeyn Colin P, Fiorella David, Janis L Scott, Lane Bethany F, Montgomery Jean, Chimowitz Marc I

机构信息

Department of Neurology, Medical University of South Carolina, Charleston, South Carolina.

Department of Neurology, Medical University of South Carolina, Charleston, South Carolina.

出版信息

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.

Abstract

BACKGROUND

Lifestyle modification programs have improved the achievement of risk factor targets in a variety of clinical settings, including patients who have previously suffered a stroke or transient ischemic attack and those with multiple risk factors. Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) was the first vascular disease prevention trial to provide a commercially available lifestyle modification program to enhance risk factor control. We sought to determine the relationship between compliance with this program and risk factor control in SAMMPRIS.

METHODS

SAMMPRIS aggressive medical management included a telephonic lifestyle modification program provided free of charge to all subjects (n = 451) during their participation in the study. Subjects with fewer than 3 expected lifestyle-coaching calls were excluded from these analyses. Compliant subjects (n = 201) had  greater than or equal to 78.5% of calls (median % of completed/expected calls). Noncompliant subjects (n = 200) had less than 78.5% of calls or refused to participate. Mean risk factor values or % in-target for each risk factor was compared between compliant versus noncompliant subjects, using t tests and chi-square tests. Risk factor changes from baseline to follow-up were compared between the groups to account for baseline differences.

RESULTS

Compliant subjects had better risk factor control throughout follow-up for low-density lipoprotein, systolic blood pressure (SBP), hemoglobin A1c (HgA1c), non-high-density lipoprotein, nonsmoking, and exercise than noncompliant subjects, but there was no difference for body mass index. After adjusting for baseline differences between the groups, compliant subjects had a greater change from baseline than noncompliant subjects for SBP did at 24 months and HgA1c at 6 months.

CONCLUSION

SAMMPRIS subjects who were compliant with the lifestyle modification program had better risk factor control during the study for almost all risk factors.

摘要

背景

生活方式改变计划已在多种临床环境中提高了危险因素目标的达成情况,包括既往有中风或短暂性脑缺血发作的患者以及有多种危险因素的患者。颅内狭窄复发性中风预防的支架置入积极药物治疗(SAMMPRIS)是首个提供可商业化的生活方式改变计划以加强危险因素控制的血管疾病预防试验。我们试图确定SAMMPRIS中对该计划的依从性与危险因素控制之间的关系。

方法

SAMMPRIS积极药物治疗包括一项在所有受试者(n = 451)参与研究期间免费提供的电话生活方式改变计划。少于3次预期生活方式指导电话的受试者被排除在这些分析之外。依从性受试者(n = 201)的通话次数大于或等于预期通话次数的78.5%(完成/预期通话次数的中位数百分比)。不依从性受试者(n = 200)的通话次数少于78.5%或拒绝参与。使用t检验和卡方检验比较依从性与不依从性受试者之间每个危险因素的平均危险因素值或达标百分比。比较两组从基线到随访的危险因素变化以考虑基线差异。

结果

在整个随访期间,依从性受试者在低密度脂蛋白、收缩压(SBP)、糖化血红蛋白(HgA1c)、非高密度脂蛋白、戒烟和运动方面的危险因素控制优于不依从性受试者,但体重指数方面无差异。在调整两组之间的基线差异后,依从性受试者在24个月时SBP和6个月时HgA1c相对于基线的变化大于不依从性受试者。

结论

在SAMMPRIS中,依从生活方式改变计划的受试者在研究期间几乎对所有危险因素都有更好的危险因素控制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验